All groups had a similar change in Hb during the first 48 h in both trial strata, at which point recovery stalled within the SCA groups, leaving both significantly more anemic at Day 28 (Figure 1A–D). This evidence concerns the gene GSTM1 and autosomal dominant cerebellar ataxia.